@article{28d89f8a0618422a91ff15f28cb49625,
title = "Objectively measured access to recreational destinations and leisure-time physical activity: Associations and demographic moderators in a six-country study",
abstract = "Within the growing body of research linking neighbourhood environmental attributes with physical activity, associations between recreational destinations and non-walking leisure-time physical activity (LTPA) are rarely studied, and to date, not across multiple cities. We examined six potential associations of objectively-measured access to private recreational facilities (e.g., fitness centres, swimming pools) and parks with adults{\textquoteright} non-walking LTPA (e.g., swimming, cycling, tennis), using data gathered with consistent methods from adults living in international cities with a range of environment attributes. The potential effects of socio-demographic moderators and between-city variations were also examined. Data from 6725 adults from 10 cities (6 countries) were gathered. Adults were more likely to engage in non-walking LTPA if they had a greater number of private recreational facilities within 0.5 or 1 km of the home, particularly in women, and if they lived closer to a park. The amount of non-zero LTPA was only associated (positively) with the number of recreational facilities within 1 km. Relationships between amount of LTPA and park proximity appear complex, with likely contextual and cultural differences. Improving access to private recreational facilities could promote non-walking LTPA, especially in women.",
keywords = "Geographic information systems, Moderation, Parks, Physical activity, Recreation facilities",
author = "Christopher Gidlow and E. Cerin and Takemi Sugiyama and Adams, {Marc A.} and J. Mitas and Muhammad Akram and Reis, {Rodrigo S.} and Rachel Davey and Jens Troelsen and G. Schofield and Sallis, {James F.}",
note = "Funding Information: All authors declare financial support for the submitted work from the National Cancer Institute of the National Institutes of Health . US data collection and Coordinating Centre processing was supported by the following NIH grants: R01 HL67350 (NHLBI) and R01 CA127296 (NCI) . The Danish study was partly funded by the Municipality of Aarhus. Data collection in the Czech Republic was supported by the grant MEYS ( # MSM 6198959221 ). Data collection in New Zealand was supported by the Health Research Council of New Zealand grant # 07/356 . Data collected for the UK was in part funded by the Medical Research Council (NPRI Initiative) , grant number: 75376 . James F Sallis received grants and personal fees from the Robert Wood Johnson Foundation outside of submitted work, grants and non-financial support from Nick, Inc. outside of submitted work, is a Santech, Inc. shareholder and is a consultant and receiver of royalties from SPARK Programs of School Specialty, Inc. Ester Cerin is supported by an Australian Research Council Future Fellowship ( FT3 #140100085 ). The funding bodies had no input in study design and the collection, analysis and interpretation of data and the writing of the article and the decision to submit it for publication. All authors are independent from the funding bodies. Funding Information: Dr James Sallis is the principal investigator on the IPEN coordinating grant funded by the National Institutes of Health , National Cancer Institute . Ethics Committee approval for the lead grant was obtained from Dr Sallis' institution, the University of California, San Diego , Institutional Review Board (Biomedical Committee) and San Diego State University . Additionally, as a requirement for participation in the IPEN study, all 6 countries providing data obtained approval from the Ethics Committee at each principal investigator's home institution. Funding Information: Dr James Sallis is the principal investigator on the IPEN coordinating grant funded by the National Institutes of Health, National Cancer Institute. Ethics Committee approval for the lead grant was obtained from Dr Sallis' institution, the University of California, San Diego, Institutional Review Board (Biomedical Committee) and San Diego State University. Additionally, as a requirement for participation in the IPEN study, all 6 countries providing data obtained approval from the Ethics Committee at each principal investigator's home institution.All authors declare financial support for the submitted work from the National Cancer Institute of the National Institutes of Health. US data collection and Coordinating Centre processing was supported by the following NIH grants: R01 HL67350 (NHLBI) and R01 CA127296 (NCI). The Danish study was partly funded by the Municipality of Aarhus. Data collection in the Czech Republic was supported by the grant MEYS (# MSM 6198959221). Data collection in New Zealand was supported by the Health Research Council of New Zealand grant # 07/356. Data collected for the UK was in part funded by the Medical Research Council (NPRI Initiative), grant number: 75376. James F Sallis received grants and personal fees from the Robert Wood Johnson Foundation outside of submitted work, grants and non-financial support from Nick, Inc. outside of submitted work, is a Santech, Inc. shareholder and is a consultant and receiver of royalties from SPARK Programs of School Specialty, Inc. Ester Cerin is supported by an Australian Research Council Future Fellowship (FT3 #140100085). The funding bodies had no input in study design and the collection, analysis and interpretation of data and the writing of the article and the decision to submit it for publication. All authors are independent from the funding bodies. Publisher Copyright: {\textcopyright} 2019 Elsevier Ltd",
year = "2019",
month = sep,
doi = "10.1016/j.healthplace.2019.102196",
language = "English (US)",
volume = "59",
journal = "Health and Place",
issn = "1353-8292",
publisher = "Elsevier Limited",
}